A detailed history of Bank Of Montreal transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 2,086,322 shares of ADMA stock, worth $36.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,086,322
Previous 1,597,002 30.64%
Holding current value
$36.3 Million
Previous $17.9 Million 133.59%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.21 - $20.03 $5.49 Million - $9.8 Million
489,320 Added 30.64%
2,086,322 $41.7 Million
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $9.55 Million - $17.9 Million
1,597,002 New
1,597,002 $17.9 Million
Q2 2022

Aug 11, 2022

SELL
$1.43 - $2.2 $1.3 Million - $2 Million
-910,000 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.28 - $1.83 $1.16 Million - $1.67 Million
910,000 New
910,000 $1.67 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.